LEADER 03483nam 22005535 450 001 9910392733503321 005 20250609111434.0 010 $a981-15-3773-9 024 7 $a10.1007/978-981-15-3773-8 035 $a(CKB)4100000011219804 035 $a(MiAaPQ)EBC6187809 035 $a(DE-He213)978-981-15-3773-8 035 $a(PPN)243760078 035 $a(MiAaPQ)EBC6187741 035 $a(EXLCZ)994100000011219804 100 $a20200430d2020 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPathology of Peritoneal Metastases $eThe Unchartered Fields /$fedited by Olivier Glehen, Aditi Bhatt 205 $a1st ed. 2020. 210 1$aSingapore :$cSpringer Singapore :$cImprint: Springer,$d2020. 215 $a1 online resource (ix, 279 pages) 311 08$a981-15-3772-0 327 $aMechanisms of peritoneal cancer dissemination and their clinical implications -- Data set for reporting peritonectomy specimens -- Patterns of peritoneal dissemination in colorectal cancer -- Patterns of peritoneal dissemination in ovarian cancer -- Peritoneal mesothelioma- disease biology and patterns of peritoneal dissemination -- Patterns of peritoneal recurrence following cytoreductive surgery -- The pathological spectrum of pseudomyxoma peritonei -- Rare peritoneal tumors- essentials for diagnosis and reporting -- Approach to a patient with peritoneal metastases with unknown primary site -- Biomarkers and the management of peritoneal metastases- A future perspective. 330 $aThis book covers some well-known and some unexplored pathological aspects of management of peritoneal metastases and should be read by both surgeons and pathologists involved in the management of peritoneal surface malignancies. The evaluation of cytoreductive surgery specimens is explored for the prognostic information it can provide and recommendations for evaluation of such specimens are provided. The pathways and patterns of peritoneal dissemination and their clinical implications on the extent of surgery performed and other aspects of management are discussed for some common peritoneal tumours. The exploratory studies presented here provide a new perspective on the surgical resection of peritoneal metastases. Other important aspects of pathological evaluation like pathological response to chemotherapy, diagnosis and classification of rare peritoneal tumors have also been covered in different chapters. Keeping in sync with the progress in molecular oncology, the role of molecular oncology in the current and future management of peritoneal metastases is addressed for different tumors. . 606 $aOncology 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 606 $aPeritoneu$2thub 606 $aMetāstasi$2thub 606 $aOncologia$2thub 608 $aLlibres electrōnics$2thub 615 0$aOncology. 615 14$aOncology. 615 7$aPeritoneu 615 7$aMetāstasi 615 7$aOncologia 676 $a616.99465 702 $aGlehen$b Olivier$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aBhatt$b Aditi$4edt$4http://id.loc.gov/vocabulary/relators/edt 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910392733503321 996 $aPathology of Peritoneal Metastases$92079608 997 $aUNINA